233 related articles for article (PubMed ID: 25776301)
1. Mutant prevention concentration, pharmacokinetic-pharmacodynamic integration, and modeling of enrofloxacin data established in diseased buffalo calves.
Ramalingam B; Sidhu PK; Kaur G; Venkatachalam D; Rampal S
J Vet Pharmacol Ther; 2015 Dec; 38(6):529-36. PubMed ID: 25776301
[TBL] [Abstract][Full Text] [Related]
2. Mutant prevention concentration and PK-PD relationships of enrofloxacin for Pasteurella multocida in buffalo calves.
Balaje RM; Sidhu PK; Kaur G; Rampal S
Res Vet Sci; 2013 Dec; 95(3):1114-24. PubMed ID: 23941961
[TBL] [Abstract][Full Text] [Related]
3. Implications for dosing regimen of enrofloxacin administered concurrently with dexamethasone in febrile buffalo calves.
Sidhu PK; Ramalingam B; Kaur G; Rampal S; Coetzee JF
Trop Anim Health Prod; 2020 May; 52(3):1093-1102. PubMed ID: 31701397
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic and pharmacodynamic testing of marbofloxacin administered as a single injection for the treatment of bovine respiratory disease.
Vallé M; Schneider M; Galland D; Giboin H; Woehrlé F
J Vet Pharmacol Ther; 2012 Dec; 35(6):519-28. PubMed ID: 22126438
[TBL] [Abstract][Full Text] [Related]
5. PK-PD integration and modeling of marbofloxacin in sheep.
Sidhu PK; Landoni MF; Aliabadi FS; Lees P
Res Vet Sci; 2010 Feb; 88(1):134-41. PubMed ID: 19523661
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic/pharmacodynamic integration and modelling of amoxicillin for the calf pathogens Mannheimia haemolytica and Pasteurella multocida.
Lees P; Pelligand L; Illambas J; Potter T; Lacroix M; Rycroft A; Toutain PL
J Vet Pharmacol Ther; 2015 Oct; 38(5):457-70. PubMed ID: 25669418
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and pharmacokinetic/pharmacodynamic integration of marbofloxacin in calf serum, exudate and transudate.
Aliabadi FS; Lees P
J Vet Pharmacol Ther; 2002 Jun; 25(3):161-74. PubMed ID: 12081611
[TBL] [Abstract][Full Text] [Related]
8. Prediction of marbofloxacin dosage for the pig pneumonia pathogens Actinobacillus pleuropneumoniae and Pasteurella multocida by pharmacokinetic/pharmacodynamic modelling.
Dorey L; Pelligand L; Lees P
BMC Vet Res; 2017 Jul; 13(1):209. PubMed ID: 28666426
[TBL] [Abstract][Full Text] [Related]
9. Integrated pharmacokinetics/pharmacodynamics parameters-based dosing guidelines of enrofloxacin in grass carp Ctenopharyngodon idella to minimize selection of drug resistance.
Xu L; Wang H; Yang X; Lu L
BMC Vet Res; 2013 Jun; 9():126. PubMed ID: 23800340
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetic and pharmacodynamic characterization of ceftiofur crystalline-free acid following subcutaneous administration in domestic goats.
Waraich GS; Sidhu PK; Daundkar PS; Kaur G; Sharma SK
J Vet Pharmacol Ther; 2017 Oct; 40(5):429-438. PubMed ID: 27943295
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic-Pharmacodynamic Modeling of Enrofloxacin Against Escherichia coli in Broilers.
Sang K; Hao H; Huang L; Wang X; Yuan Z
Front Vet Sci; 2015; 2():80. PubMed ID: 26779495
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic and pharmacodynamic integration and modelling of marbofloxacin in calves for Mannheimia haemolytica and Pasteurella multocida.
Potter T; Illambas J; Pelligand L; Rycroft A; Lees P
Vet J; 2013 Jan; 195(1):53-8. PubMed ID: 23084327
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic/pharmacodynamic relationship of marbofloxacin against Pasteurella multocida in a tissue-cage model in yellow cattle.
Shan Q; Wang J; Yang F; Ding H; Liang C; Lv Z; Li Z; Zeng Z
J Vet Pharmacol Ther; 2014 Jun; 37(3):222-30. PubMed ID: 24033339
[TBL] [Abstract][Full Text] [Related]
14. Comparative mutant prevention concentration and antibacterial activity of fluoroquinolones against Escherichia coli in diarrheic buffalo calves.
Beri S; Sidhu PK; Kaur G; Chandra M; Rampal S
J Chemother; 2015 Oct; 27(5):312-6. PubMed ID: 24575977
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetic and pharmacodynamic modelling of marbofloxacin administered alone and in combination with tolfenamic acid in calves.
Sidhu PK; Landoni MF; Aliabadi MH; Toutain PL; Lees P
J Vet Pharmacol Ther; 2011 Aug; 34(4):376-87. PubMed ID: 21091727
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic/pharmacodynamic relationship of enrofloxacin against Aeromonas hydrophila in crucian carp (Carassius auratus gibelio).
Shan Q; Wang J; Wang J; Ma L; Yang F; Yin Y; Huang R; Liu S; Li L; Zheng G
J Vet Pharmacol Ther; 2018 Dec; 41(6):887-893. PubMed ID: 29943470
[TBL] [Abstract][Full Text] [Related]
17. Limitations of MIC as sole metric of pharmacodynamic response across the range of antimicrobial susceptibilities within a single bacterial species.
Wen X; Gehring R; Stallbaumer A; Riviere JE; Volkova VV
Sci Rep; 2016 Dec; 6():37907. PubMed ID: 27905408
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics and dosage regimen of enrofloxacin in buffalo bulls after intramuscular administration.
Verma HK; Pangawkar GR; Chaudhary RK; Srivastava AK
Vet Res Commun; 1999 Dec; 23(8):501-5. PubMed ID: 10672966
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic-pharmacodynamic integration and modelling of florfenicol in calves.
Sidhu P; Rassouli A; Illambas J; Potter T; Pelligand L; Rycroft A; Lees P
J Vet Pharmacol Ther; 2014 Jun; 37(3):231-42. PubMed ID: 24341543
[TBL] [Abstract][Full Text] [Related]
20. The dose regimen formulation of tilmicosin against Lawsonia intracellularis in pigs by pharmacokinetic-pharmacodynamic (PK-PD) model.
Luo W; Qin H; Chen D; Wu M; Meng K; Zhang A; Pan Y; Qu W; Xie S
Microb Pathog; 2020 Oct; 147():104389. PubMed ID: 32707311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
